Cargando…
Reactive Arthritis After COVID-19: A Case Report
A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated wi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106556/ https://www.ncbi.nlm.nih.gov/pubmed/35573487 http://dx.doi.org/10.7759/cureus.24096 |
_version_ | 1784708314683146240 |
---|---|
author | Basheikh, Mohammed |
author_facet | Basheikh, Mohammed |
author_sort | Basheikh, Mohammed |
collection | PubMed |
description | A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated with nonsteroidal anti-inflammatory drugs (NSAIDs), a short course of systemic steroids, and a local steroid cream on the penile lesion, followed by a local antifungal cream for two months. The patient responded well to the treatment and returned to his usual life activities. |
format | Online Article Text |
id | pubmed-9106556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91065562022-05-14 Reactive Arthritis After COVID-19: A Case Report Basheikh, Mohammed Cureus Internal Medicine A 43-year-old healthy male was diagnosed with symptomatic COVID-19. Soon after recovery, he experienced severe back pain, bilateral red eye, and a new penile lesion. He was diagnosed with reactive arthritis, given he presented with arthritis, conjunctivitis, and balanitis. The patient was treated with nonsteroidal anti-inflammatory drugs (NSAIDs), a short course of systemic steroids, and a local steroid cream on the penile lesion, followed by a local antifungal cream for two months. The patient responded well to the treatment and returned to his usual life activities. Cureus 2022-04-13 /pmc/articles/PMC9106556/ /pubmed/35573487 http://dx.doi.org/10.7759/cureus.24096 Text en Copyright © 2022, Basheikh et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Basheikh, Mohammed Reactive Arthritis After COVID-19: A Case Report |
title | Reactive Arthritis After COVID-19: A Case Report |
title_full | Reactive Arthritis After COVID-19: A Case Report |
title_fullStr | Reactive Arthritis After COVID-19: A Case Report |
title_full_unstemmed | Reactive Arthritis After COVID-19: A Case Report |
title_short | Reactive Arthritis After COVID-19: A Case Report |
title_sort | reactive arthritis after covid-19: a case report |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106556/ https://www.ncbi.nlm.nih.gov/pubmed/35573487 http://dx.doi.org/10.7759/cureus.24096 |
work_keys_str_mv | AT basheikhmohammed reactivearthritisaftercovid19acasereport |